Vice President, US Patient Access
Travere Therapeutics
Summary
The Vice President, U.S. Patient Access is responsible for leading Travere's end-to-end U.S. patient access platform across the commercial portfolio. This role oversees the capabilities required to help appropriate patients access, initiate, receive, and remain on Travere therapies.
Job description
The scope of the role includes payer management, field access and reimbursement, contracting operations, rebate adjudication, government price reporting, hub and patient services operations, specialty pharmacy, trade and distribution, and affordability and free-goods programs.
The Vice President partners closely with the U.S. Sales Organization and leaders from Franchise Strategy, Insights & Analytics, Medical Affairs, Finance, Legal, Compliance and Enterprise Technology Solutions to translate product-specific strategies into effective execution to continuously improve patient access.
The Vice President is accountable for the performance, operating model, infrastructure, controls, and service delivery required to support FILSPARI and future portfolio assets. This leader will ensure that Travere's patient access capabilities are scalable, compliant, financially responsible, and focused on delivering effective experiences for patients, caregivers, healthcare providers, and other access stakeholders.
Responsibilities
- Lead Travere's U.S. Patient Access organization, setting its vision, operating model, priorities, capabilities, and performance expectations.
- Own portfolio access performance, analytics, service quality, and resolution of significant access barriers.
- Lead payer management and field access & reimbursement teams, including account planning, deployment, access pull-through, and patient-start support.
- Partner with Product and Franchise Leadership to translate product strategies into effective access execution; partner with Sales Leadership to allow for seamless conversion of generated demand.
- Oversee the end-to-end patient and provider experience, including hub services, affordability programs, specialty pharmacy, trade, and distribution.
- Lead contracting administration, rebate adjudication, government price reporting, gross-to-net support, financial controls, and the Patient Access budget.
- Maintain strong vendor governance, compliance, program integrity, audit readiness, risk management, and business continuity.
- Partner with Commercial Operations and Enterprise Technology Solutions on field alignment, incentive compensation, reporting, data infrastructure, and an integrated CRM platform.
- Build scalable capabilities for product launches and portfolio growth while developing a high-performing, patient-focused organization.
Education/Experience Requirements
- Bachelor's degree required; advanced degree preferred.
- 15+ years of progressive biopharmaceutical experience, including significant leadership in patient access, reimbursement, patient services, or related commercial operations.
- Demonstrated success in leading commercial organizations, including field Access and Reimbursement teams, and partnering with Sales to resolve access barriers.
- Strong analytical and financial acumen, including performance measurement, data-driven decision-making, budget management, contracting, rebates, and gross-to-net considerations.
- Proven ability to collaborate across commercial, medical, finance, legal, and compliance functions and build scalable platforms for marketed products and future launches.
- Experience in rare disease, specialty pharmaceuticals, or similarly complex access environments strongly preferred.
Additional Skills/Experience/Requirements
- Strong executive presence and communication skills, with the ability to influence senior leaders and build alignment in a matrixed environment.
- Sound judgment and problem-solving skills, balancing strategy, execution, and patient impact.
- Highly organized and adaptable, with the ability to manage competing priorities and build scalable processes in a fast-paced environment.
- Leadership style grounded in accountability, collaboration, and continuous improvement.
- Ability to travel domestically up to 35% and work face-to-face with colleagues, including onsite in San Diego; this role is not fully remote.
Requirements
- Bachelor's degree required
- 15+ years of progressive biopharmaceutical experience
- Significant leadership in patient access, reimbursement, patient services, or related commercial operations
- Demonstrated success in leading commercial organizations, including field Access and Reimbursement teams
- Strong analytical and financial acumen
- Proven ability to collaborate across commercial, medical, finance, legal, and compliance functions
- Strong executive presence and communication skills
- Ability to travel domestically up to 35%
Benefits
- Health insurance
- Financial offerings
- Work-life balance programs
- Well-being offerings
- Wellness programs
- Employee support programs
- Life insurance
- Disability insurance
- Retirement plans
- Employer match
- Paid time off
Company overview
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases. Founded in 2011 as Retrophin and rebranded as Travere Therapeutics in 2020, the company has established itself as a leader in rare disease therapeutics with a focused pipeline targeting conditions with significant unmet medical needs. Their flagship product, FILSPARI® (sparsentan), received full FDA approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) who are at risk for disease progression. The company also has a Phase 3 clinical program for pegtibatinase (TVT-058) targeting classical homocystinuria (HCU), a rare genetic metabolic disorder. Travere maintains a commercial portfolio including Thiola EC® and Thiola® for cystinuria, demonstrating their commitment to serving rare disease communities through comprehensive therapeutic solutions. With a global presence and strategic partnerships, Travere Therapeutics continues to advance innovative treatments while supporting patient access and education initiatives for rare disease populations.